Article
Discovery of zerumbone as a new agent for cardiac hypertrophy by high-throughput screening using human embryonic stem cell-derived cardiomyocytes
2022-04-13
Abstract excerpt
<title>Abstract</title> <p><bold>Background</bold>: Pathological cardiac hypertrophy is considered an adaptive response of the heart due to cardiovascular diseases such as hypertension, aortic and valvular stenosis, and inherited cardiomyopathy caused by mutations in sarcomeric proteins. It is a risk factor of various forms of cardiovascular diseases and closely associated with heart failure. Current medications...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 6399d80b-834f-51a9-a586-72d432e14778
- DOI
- 10.21203/rs.3.rs-574349/v1
